BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ahangarzadeh S, Payandeh Z, Arezumand R, Shahzamani K, Yarian F, Alibakhshi A. An update on antiviral antibody-based biopharmaceuticals. Int Immunopharmacol 2020;86:106760. [PMID: 32645633 DOI: 10.1016/j.intimp.2020.106760] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Sun D, Hsu A, Quiroz J, He X, Whiteman MC, Gurney KB, Dellatore S. Development and comparison of three cell-based potency assays for anti-respiratory syncytial virus monoclonal antibody. Biologicals 2021:S1045-1056(21)00083-X. [PMID: 34716091 DOI: 10.1016/j.biologicals.2021.10.001] [Reference Citation Analysis]
2 Hwang J, Jung Y, Moon S, Yu S, Oh H, Kim S, Kim KW, Yoon JH, Chun J, Kim SJ, Chung WJ, Kweon DH. Nanodisc-Mediated Conversion of Virustatic Antiviral Antibody to Disrupt Virus Envelope in Infected Cells. Small Methods 2022;:e2101516. [PMID: 35107214 DOI: 10.1002/smtd.202101516] [Reference Citation Analysis]
3 Zheng F, Zhou J, Ouyang Z, Zhang J, Wang X, Muyldermans S, Van Ginderachter J, Devoogdt N, Wen Y, Schoonooghe S, Raes G. Development and Characterization of Nanobodies Targeting the Kupffer Cell. Front Immunol 2021;12:641819. [PMID: 33692811 DOI: 10.3389/fimmu.2021.641819] [Reference Citation Analysis]
4 Sokullu E, Gauthier MS, Coulombe B. Discovery of Antivirals Using Phage Display. Viruses 2021;13:1120. [PMID: 34200959 DOI: 10.3390/v13061120] [Reference Citation Analysis]
5 Nawab DH. Vaccinal antibodies: Fc antibody engineering to improve the antiviral antibody response and induce vaccine-like effects. Hum Vaccin Immunother 2021;:1-14. [PMID: 34844516 DOI: 10.1080/21645515.2021.1985891] [Reference Citation Analysis]
6 Da Costa CBP, Cruz ACM, Penha JCQ, Castro HC, Da Cunha LER, Ratcliffe NA, Cisne R, Martins FJ. Using in vivo animal models for studying SARS-CoV-2. Expert Opin Drug Discov 2021;:1-17. [PMID: 34727803 DOI: 10.1080/17460441.2022.1995352] [Reference Citation Analysis]
7 Mercer DK, Francis ML, Fraser-Pitt D. Antimicrobial immunotherapeutics: past, present and future. Emerg Top Life Sci 2021:ETLS20200348. [PMID: 34196722 DOI: 10.1042/ETLS20200348] [Reference Citation Analysis]
8 Redwan EM, Elrashdy F, Aljabali AAA, Baetas-da-cruz W, Barh D, Brufsky AM, Hassan SS, Lundstrom K, Serrano-aroca Á, Takayama K, Tambuwala MM, Uhal BD, Uversky VN. Would New SARS-CoV-2 Variants Change the War against COVID-19? Epidemiologia 2022;3:229-37. [DOI: 10.3390/epidemiologia3020018] [Reference Citation Analysis]